Alnylam Pharmace. buy kyron7htx
Start price
08.02.19
/
50%
€69.33
Target price
04.11.21
€108.24
Performance (%)
116.51%
End price
17.07.21
€150.10
Summary
This prediction ended on 17.07.21 with a price of €150.10. With a performance of 116.51% the BUY prediction by kyron7htx was a big success. kyron7htx has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 7.946% | 7.946% | 19.123% | 50.602% |
| iShares Core DAX® | 1.432% | 1.580% | 13.249% | 61.139% |
| iShares Nasdaq 100 | 1.892% | -2.280% | 2.995% | 88.335% |
| iShares Nikkei 225® | -1.619% | 7.954% | 27.694% | 65.180% |
| iShares S&P 500 | 1.921% | -0.277% | 2.994% | 61.153% |
Comments by kyron7htx for this prediction
In the thread Alnylam Pharmace. diskutieren
Neueinstieg
nach Stopploss.
Stopped prediction by kyron7htx for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€76.96
05.02.19
05.02.19
€108.24
07.02.19
07.02.19
-5.47%
07.02.19
07.02.19
